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Objective: The aim of the present study was to investigate the association of neutrophil/
lymphocyte ratio (NLR) with coronary artery calcium score (CACS) and obstructive coronary 
artery disease (CAD) detected by multislice computed tomography (MSCT) angiography in 
type 2 diabetes mellitus (T2DM) patients.
Methods: Two hundred and ninety-two T2DM patients, who were either asymptomatic or 
symptomatic (but noncharacteristic) for coronary artery disease (CAD) and underwent MSCT 
angiography in our clinic between May 2009 and June 2014, were enrolled. All patients were 
divided into two groups according to their mean NLR values. Patients with NLR 2.05 were 
assigned to Group 1 and patients with NLR 2.05 were assigned to Group 2. The association 
of NLR with CACS and obstructive CAD, which were detected by MSCT angiography, was 
investigated in T2DM patients.
Results: According to the Agatston scoring method, the mean CACS was 129.5±209.8 Au 
in Group 1 and 290.3±399.6 Au in Group 2 (P0.001). Obstructive CAD was detected in 
40 (26.8%) patients in Group 1 and in 56 (39.2%) patients in Group 2 (P0.05, P=0.021).
Conclusion: The rate of obstructive CAD was significantly higher in the T2DM patients with 
NLR 2.05 than that in the T2DM patients with NLR 2.05. In addition, the CACS was also 
significantly higher in the T2DM patients with NLR 2.05 than that in the T2DM patients 
with NLR 2.05.
Keywords: neutrophil, lymphocytes, coronary atherosclerosis, coronary calcium score, mul-
tislice computed tomography, type 2 diabetes mellitus
Introduction
Type 2 diabetes mellitus (T2DM) is a prevalent disease affecting many people all over 
the world and its worldwide prevalence was 6.6% in 2010.1 Cardiovascular diseases are 
the leading causes of morbidity and mortality in diabetic patients.2 A positive associa-
tion has been defined between atherosclerosis and various inflammatory conditions 
such as T2DM, hypertension (HT), obesity, and smoking.3
The number of persons suffering from T2DM is expected to approximately double in 
the next 25 years. The count of persons with T2DM will be increasing from 175 million 
individuals in 2000 to 353 million in 2030.4 T2DM is the major health problem encoun-
tered by the developing countries. If T2DM can be early diagnosed, T2DM-related 
diseases such as cardiovascular disease and systemic complications can be prevented.5 
Atherosclerosis is a T2DM-related problem, and it is a source of cardiovascular disease.6 
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Metabolic changes due to T2DM can impair the vascular walls, 
and this condition plays an important role in atherosclerotic 
plaque development.6
American Diabetes Association defined prediabetes as 
a metabolic clinical condition that leads to predisposition 
for the future development of T2DM.7 Impaired fasting 
glucose (IFG) and/or impared glucose tolerance (IGT) 
are two main conditions of prediabetes. IFG is defined as 
a fasting plasma glucose levels ranging from 100 mg/dL 
(5.6 mmol/L) to 125 mg/dL (6.9 mmol/L). IGT as a con-
dition characterized by 2-hour values of plasma glucose 
in the oral glucose tolerance test ranging from 140 mg/dL 
(7.8 mmol/L) to 199 mg/dL (11.0 mmol/L). Additionally 
a glycated hemoglobin (HbA1C) plasma levels ranging 
from 5.7% to 6.4% is further considered as a prediabetic 
condition.7
T2DM persons who have developed cardiac dysfunc-
tion have several molecular signaling pathways that were 
broken.8,9 Hyperinsulinemia, hyperglycemia, and insulin 
resistance affect oxidative stress molecules, and oxidative 
stress molecules increase may start initial damages to cardiac 
cells.10,11 The disorder of oxidative metabolism increases 
free fatty acids circulation and lipid metabolism, and this 
process ends up with lipid accumulation and lipotoxicity in 
the heart.12
Inflammation plays an important role in all stages of coro-
nary artery disease (CAD).13 Atherosclerosis is a complex 
inflammatory disease.14 Leukocytes make substantial contri-
bution to this inflammatory process.15 In several prospective 
studies, a positive correlation has been demonstrated between 
total and different leukocyte counts and future cardiovas-
cular events in healthy subjects.16,17 Recently, neutrophil/
leukocyte ratio (NLR) has appeared as a new inflammatory 
biomarker.18
In one study, NLR was higher in patients with hemo-
dynamically significant coronary artery stenosis. NLR was 
found to be an independent predicting factor for hemody-
namically significant coronary artery stenosis as measured 
by fractional flow reserve (FFR).19
Another study shows that platelet count, white blood cell 
count, creatinine, glycemia, uric acid, and C-reactive protein 
levels affected NLR. NLR was inversely related to total 
cholesterol, triglycerides, and hemoglobin. The NLR was 
associated with multiple CAD, anterior descending CAD, 
right CAD, branch lesions of circumflex CAD, coronary 
artery stenosis percentage, coronary artery calcification, 
and coronary artery trombosis. It was shown that NLR was 
associated with CAD and severity.20
One study shows that there is a relationship between 
neutrophil gelatinase-associated lipocalin (NGAL) and the 
degree of aortic stiffness. Patients with noncritical CAD have 
higher degree of aortic stiffness and NGAL level. According 
to this study, NGAL can be used as a tool for risk stratifica-
tion in patients with noncritical CAD.21
Moro-Garcia et al have shown that the patients who have 
acute coronary syndrome have higher immune response.22
There is a strong parallelism between coronary artery 
wall calcification and atherosclerotic CAD.23 It is known 
that detection of amount and distribution of coronary artery 
calcification and performing coronary artery calcium scor-
ing (CACS) are important parameters for the prediction of 
cardiovascular risk.24–26 Multislice computed tomography 
(MSCT) coronary angiography is considered as a noninvasive 
modality in detecting and classifying CAD.27,28
The aim of the present study was to investigate the asso-
ciation of NLR with CACS and obstructive CAD detected 
by MSCT angiography in type 2 diabetic patients.
Methods
clinical characteristics of patients
The present study comprised 292 T2DM patients, who were 
either asymptomatic or symptomatic (but most of them were 
noncharacteristic) for coronary artery disease (CAD) and had 
undergone MSCT angiography in our clinic. The study com-
prised patients who had nonspecific or stable angina and were 
in New York Heart Association class II or lower and admitted 
to the Cardiology or Internal Medicine Polyclinic. The patients 
did not have any complaints except chest pain. They had no 
autoimmune disease and were found to have no infection. 
The patients who had WBC count out of the normal range 
(4,000–12,000 cells/µL), acute infection, autoimmunological 
diseases, and any other disease (such as urinary system infec-
tion, cholecystitis) that could affect WBC count were excluded. 
Data were collected retrospectively, and the approval of the 
Ethics Committee (Medical School, Selçuk University, Konya, 
Turkey) was obtained. Our study was designed and managed 
according to the Declaration of Helsinki.
Cardiovascular risk factors
All participants were explored in terms of risk factors for CAD 
including smoking, HT, T2DM, hyperlipidemia, and family 
history of CAD. Smoking related to ischemic CAD. People 
who are living in our country use cigarette.
T2DM was defined in patients with HbA
1c
 level 
of 6.5% (48 mmol/L) and a fasting plasma glucose level 
of 7.0 mmol/L (126 mg/dL). Serum glucose and HbA
1c
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levels were detected using Cobast integra 800 (Hoffman-La 
Roche Ltd., Basel, Switzerland).
HT as medical term is characterized by systolic tension 
140 mmHg or diastolic tension 90 mmHg in adult per-
sons (18 years of age). These measurements have to be 
done on two different days and using blood pressure tools 
calibrated.
Dyslipidemia was defined in patients with a fasting total 
cholesterol serum level of 240 mg/dL, serum level of 
triglyceride 200 mg/dL, low-density lipoprotein (LDL) 
cholesterol 160 mg/dL, and/or high-density lipoprotein (HDL) 
cholesterol 40 mg/dL and in patients receiving or not receiving 
medical therapy for dyslipidemia.29 Serum cholesterol levels were 
detected using Cobast integra 800 (Hoffman-La Roche Ltd.).
Before computerized tomography scanning, height 
(Human scale; NAN Tarti Co., Turkey) and weight (TANITA 
Body Composition Analyzer; TANITA Corporation, Japan) 
of the patients were measured and their body mass indexes 
(BMIs) were calculated. Patients with BMI 25 kg/m2 were 
considered to have normal weight, those with BMI between 
25 kg/m2 and 30 kg/m2 were considered overweight, and 
those with BMI 30 kg/m2 were considered obese.
coronary calcium scoring
In the first step, all patients underwent noncontrast-enhanced 
computed tomography (CT) beginning from carina extending to 
the subdiaphragmatic level (Somatom Sensation 64; Siemens, 
Forchheim, Germany). On noncontrast-enhanced CT, calcified 
coronary artery plaques were explored on cardiac sections. 
CACS was performed using preexisting software in the device 
(Syngo CaScore, Siemens; Agatston scoring method).
Total CACS was the sum of calcium levels calculated in the 
left main coronary artery, in the left anterior descending coro-
nary artery, in the circumflex coronary artery, and in the right 
coronary artery traces. Collected data were evaluated using the 
percentiles predefined according to the age and sex.30 Individual 
calcium scores were grouped as low (0–25 percentile), moderate 
(25–75 percentile), and high (75–100 percentile).
Multislice computed tomography image 
reconstruction and cAD evaluation
In the second step, all patients underwent MSCT angiography 
using Somatom Sensation 64 tomography device (Siemens), 
and scanning parameters were selected as follows: gantry 
rotation time 330 ms; tube voltage 120 kW; 250 mA; and 
detector collimation 0.6 mm. Images were obtained in a 
single breath within approximately 8.4–13.1 seconds in 
craniocaudal direction from carina to subcostal level. During 
MSCT angiography, 80–110 mL (based on the patient’s 
weight) of nonionic contrast agent (Iomeron 400; Bracco 
s.p.a., Milan, Italy) was administered through antecubital 
vein at a speed of 5.0 mL/s followed by 40 mL isotonic bolus. 
Automatic peak contrasting density through ascending aorta 
was determined to be +140 Hounsfield units. Reconstruc-
tions were obtained from the images on 0.6 mm sections 
increasing them by 0.6 mm according to the retrospective 
electrocardiography-gating technique. Images in multiplanar 
reformats and three-dimensional volume rendering format 
were created from thin axial sections, and anatomy of coro-
nary artery was evaluated.
All segments of coronary arteries were investigated 
visually. Patients were divided into groups according to the 
degree of coronary artery obstruction as normal (without or 
insignificant plaque), non-obstructive CAD (non-obsCAD; 
degree of obstruction 50% with at least one plaque), and 
obstructive CAD (obsCAD; degree of obstruction 50% 
with at least one plaque) (Figures 1 and 2). MSCT angiogra-
phy was performed by radiologists, cardiovascular surgeons, 
and cardiologists. MSCT angiography examinations were 
performed by specialists who were blinded to NLR results.
White blood cell count and neutrophil/
lymphocyte ratio
White blood cell and different subtype counts were obtained 
using automated differential leukocyte counter Sysmex 
KX-21N (TOA Medical Electronics, Kobe, Japan). Patients 
Figure 1 right coronary artery with plaque (white arrow) and left anterior desce-
nding coronary artery with plaque (black arrow).
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were divided into two groups according to their mean NLR 
values as Group 1 having NLR 2.05 and Group 2 having 
NLR 2.05. Groups were formed according to the mean 
values of the study population. MSCT angiography was 
performed in a short time (1–3 days) after WBC count 
measurement.
statistical analysis
Statistical analyses were performed using the Statistical 
Package for the Social Sciences program (SPSS Inc., Chicago, 
IL, USA). Statistical significance of nonparametric data 
between the groups was analyzed by Pearson’s chi-squared 
test. Parametric data were expressed as minimum, maximum, 
and mean ± standard deviation, and statistical significance of 
parametric data between the groups was analyzed by inde-
pendent Student’s t-test. The result was considered statisti-
cally significant if two-tailed P-value was lower than 0.05 
(P0.05). The relationship of obsCAD with CACS and NLR 
was found to be significant using multivariate analysis.
Binary logistic regression analysis was performed to 
assess the independent predictors of obsCAD. All variables 
that were found significant in univariate analysis were 
included in the model of logistic regression model, and the 
results are shown as an odds ratio with 95% confidence 
intervals. A two-tailed P0.05 was considered as statisti-
cally significant.
The relationship among NLR, CACS, and obsCAD were 
investigated using one-way analysis of variance (ANOVA) 
and post hoc analysis, which are two of the multivariate 
analysis tests. A two-tailed P-value of 0.05 was considered 
statistically significant. Multivariate analysis (one-way 
ANOVA) was performed on groups that were separated 
as normal, non-obsCAD, and obsCAD. Persons who were 
grouped as normal, non-obsCAD, and obsCAD were differ-
ent in terms of NLR (P0.05, P=0.04) and calcium scoring 
(P0.01).
Results
In our study, we saw that groups are similar with regard 
to some parameters such as age and sex. But Group 2 has 
higher rates of HT (P=0.022, P0.05), CACS (P0.001), 
and obsCAD (P=0.021, P0.05) (Table 1). Group 2 included 
persons who have high NLR. Statistical analysis was adjusted 
to the angle of these factors in Table 2. We found statistical 
significance for CACS in Group 2, which has high CACS 
(P0.001). The persons who are using antiHT agents were 
statistically similar according to drug difference in both 
groups (P0.05).
The sex differences between two groups 
regarding clinical characteristics
In the males of Group 1, the mean NLR was 1.55±0.3, the 
mean age was 54.3±8.8 years, and the mean CACS accord-
ing to the Agatston scoring was 131.7±204.8 Au, whereas 
the mean value of serum HbA
1c
 was 7.5±1.8, fasting blood 
glucose was 130.1±55.1 mg/dL, serum triglyceride was 
183.2±132.2 mg/dL, serum HDL was 45.1±14.5 mg/dL, 
and serum LDL was 116.5±35.7 mg/dL. Of the males, 
28 (21.5%) were obese, 47 (36.2%) were smokers, 33 
(25.4%) had obsCAD, 73 (56.2%) had HT, 68 (52.3%) had 
hyperlipidemia, 54 (41.5%) were receiving statin, and 85 
(65.4%) were receiving antidiabetic agent (Figure 3).
In the females of Group 1, the mean NLR was 1.6±0.33, the 
mean age was 67.1±7.3 years, and the mean coronary artery 
calcium score (CACS) according to the Agatston scoring 
was 114±247.0 Au, whereas the mean value of serum HbA
1c 
was 7.9±2.8, fasting blood glucose was 116.6±35.5 mg/dL, 
serum triglyceride was 150.4±65.2 mg/dL, serum HDL was 
57.5±20.8 mg/dL, and serum LDL was 119.4±28.8 mg/dL. 
Seven (36.8%) females were obese, and none of the females 
were smokers. Of the females, seven (36.8%) had obsCAD, 
13 (68.4%) had HT, eleven (57.9%) had hyperlipidemia, 
eleven (57.9%) were receiving statin, and nine (47.4%) were 
receiving antidiabetic agent (Figure 4).
In the males of Group 2, the mean NLR was 2.4±0.34, the 
mean age was 55.6±11.2 years, and the mean CACS according 
to the Agatston scoring was 309.8±418.0 Au, whereas the mean 
Figure 2 circumferential coronary artery with plaque (arrow).
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value of serum HbA
1c
 was 7.6±2.3, fasting blood glucose was 
128.2±42.1 mg/dL, serum triglyceride was 164.6±79.2 mg/dL, 
serum HDL was 47.2±15.0 mg/dL, and serum LDL was 
117.7±30.2 mg/dL. There were 34 (26.6%) obese subjects and 
47 (36.7%) smokers; 51 (39.8%) had obsCAD, 86 (67.2%) had 
HT, 74 (57.8%) had hyperlipidemia, 61 (47.7%) were receiving 
statin, and 84 (65.6%) were receiving antidiabetic agent.
In the females of Group 2, the mean NLR was 2.6±0.39, the 
mean age was 66.2±16.2 years, and the mean CACS according 
to the Agatston scoring was 123.7±37.4 Au, whereas the mean 
value of serum HbA
1c
 was 7.6±0.95, fasting blood glucose was 
114.2±18.5 mg/dL, serum triglyceride was 147±19.4 mg/dL, 
serum HDL was 52.2±7.4 mg/dL, and serum LDL was 
122.7±29.8 mg/dL. There were three (20%) obese subjects 
and three (20%) smokers; five (33.3%) had obsCAD, 15 
(100%) had HT, nine (60%) had hyperlipidemia, six (40%) 
were receiving statin, and 12 (80%) were receiving antidi-
abetic agent (Figure 5).
Of the 292 patients included in the groups, 162 (55.4%) 
had diagnosis of hyperlipidemia. Of these patients, 132 
Table 1 statistical data for two groups according to nlr
Group 1 (n=149)  
(NLR 2.05)
Group 2 (n=143)  
(NLR 2.05)
P-value
nlr 1.5±0.3 2.5±0.3 0.001*
Age, years (± sD) 55.9±9.6 56.7±12.2 0.520*
sex (male) 130 (87.2%) 128 (89.5%) 0.547**
Smoking 47 (31.5%) 50 (35%) 0.535**
Familial history 17 (11.4%) 19 (13.3%) 0.626**
Body mass index normal weight 32 (21.5%) 18 (12.6%)
Overweight 82 (55%) 88 (61.5%) 0.131**
Obese 35 (23.5%) 37 (25.9%)
Blood glucose level (starving) (mg/dl) 128.4±53.1 126.8±40.5 0.773*
hbA1c (last 6 months) (mg/dl) 7.5±0.9 7.6±2.2 0.660*
cholesterol (mg/dl) 194.6±1.4 195±36.8 0.935*
Triglyceride (mg/dl) 179±75.4 162.8±75.4 0.186*
high-density lipoprotein-c (mg/dl) 46.7±126 47.7±14.5 0.572*
low-density lipoprotein-c (mg/dl) 116.9±34.8 118.2±30.1 0.729*
Aspartate aminotransferase (U/L) 24.7±13.6 22.6±10.3 0.141*
Alanine aminotransferase (U/L) 32.8±25 32.7±23.3 0.978*
hyperlipidemia 79 (53%) 83 (58%) 0.388**
hypertension 86 (57.7%) 101 (70.6%) 0.022**
Antihypertension agents
Ace inhibitors 29 (33.7%) 32 (31.7%) 0.977**
Beta blockers 17 (19.8%) 20 (19.8%)
Calcium-channel blockers 29 (33.7%) 37 (36.6%)
Angiotensin receptor blockers 11 (12.8%) 12 (11.9%)
statin use 65 (43.6%) 67 (46.9%) 0.579**
Antidiabetic agent 94 (63.1%) 96 (67.1%) 0.469**
calcium scoring (Au) 129.5±209.8 290.3±399.6 0.001*
cAD disease
normal + non-obscAD 109 (73.2%) 87 (60.9%)
ObscAD 40 (26.8%) 56 (39.2%) 0.021**
Notes: *P-value was presented as a result of student’s t-test. **P-value was presented as a result of Pearson’s chi-squared test.
Abbreviations: nlr, neutrophil/lymphocyte ratio; sD, standard deviation; hbA1c, glycosylated hemoglobin; Ace, angiotensin converting enzyme; cAD, coronary artery 
disease; non-obs, non-obstructive; obs, obstructive.
Table 2 Binary logistic regression analysis was performed for hypertension and CACS, which showed statistically significant difference 
between the groups
Unadjusted OR 95% CI P-value Adjusted OR 95% CI P-value
hypertension 3.246 1.231–8.557 0.017 – – –
calcium scoring (Au) 1.009 1.007–1.012 0.001 1.009 1.007–1.011 0.001
Abbreviations: CACS, coronary artery calcium score; OR, odds ratio; CI, confidence interval.
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were using statins and 30 discontinued their therapies due 
to statin-induced hypolipidemia.
Discussion
In the present study, the rate of obsCAD detected in MSCT 
angiography in Group 2 was significantly higher than in 
Group 1 (P0.05). Moreover, CACS was significantly higher 
in Group 2 than in Group 1 (P0.05). The relationship of 
obsCAD with CACS and NLR was found to be significant 
using multivariate analysis (P=0.048, P0.001).
MSCT has been proposed as a noninvasive method for 
detection and classification of coronary artery plaques.27,28,31 
MSCT coronary angiography is an important tool to detect 
CAD in an early stage. In a study, MSCT angiography and 
invasive coronary angiography have been compared in evalu-
ating the coronary arteries and branches larger than 1.5 mm 
and the sensitivity and specificity of MSCT have been found 
to be 94% and 97%, respectively.32
Risk of future coronary heart disease is increased as the 
total amount of calcium in the coronary arteries is increased.33 
In a systematic study, while the prevalence of cardiovascular 
events in the patients with zero CACS has been found to 
be 0.56%, its negative predictive value has been found to 
be as high as 99%.34 In some studies, the risk of significant 
coronary artery stenosis (50%) has been found to be lower 
than 3% by invasive coronary angiography in the patients 
with CACS lower than 100 Au.35 In our study, when the par-
ticipants were divided into normal, non-obsCAD, obsCAD 
individuals, CACS was found to be 9.8±20.5 Au in normal 
persons, 81.3±149.8 Au in non-obsCAD persons, and 
530.7±376.5 Au in obsCAD persons (P0.001).
Atherosclerosis is a multifactorial disease includ-
ing HT, dyslipidemia, dysglycemia, smoking, and other 
cardiovascular risk factors. Recent studies have demon-
strated that atherogenesis is not a simple passive injury 
caused by the serum lipids and other substances on the 
vascular wall, but an active inflammatory process.36 Leuko-
cytes play a major role, either regenerative or pathogenic, 
in this inflammatory process.37 Functional molecules of 
inflammatory cells may lead to acute coronary syndrome 
by enhancing the progression of early atherogenic lesions.38 
Recent studies have revealed that neutrophils participate in 
many steps ranging from the development to the rupture of 
atherosclerotic plaque.13–15,35,36 In our study, CACS shows 
that the accumulation of calcium in coronary artery and 
   

1/5DQG&$&6PHDQYDOXHV
1RUPDO 1RQREV&$' 2EV&$'
1/5&$&6×
Figure 4 Multivariate analysis (one-way AnOVA) was performed on groups 
separated as normal, non-obscAD, and obscAD. Among persons who has either 
normal, or non-obscAD, or obscAD were different in terms of nlr (P0.05, 
P=0.04) and calcium scoring (P0.01).
Abbreviations: AnOVA, analysis of variance; non-obscAD, non-obstructive coronary 
artery disease; obscAD, obstructive coronary artery disease; nlr, neutrophil/
lymphocyte ratio; cAcs, coronary artery calcium score.
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Figure 5 coronary artery disease according to sex.
Abbreviations: cAD, coronary artery disease; obs, obstructive; non-obs, non-
obstructive; obs, obstructive.
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Figure 3 coronary artery disease according to groups.
Abbreviations: cAD, coronary artery disease; obs, obstructive; nlr, neutrophil/
lymphocyte ratio; non-obs, non-obstructive; obs, obstructive.
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relationship of nlr with cAD and ccs in type 2 T2DM patients
plaque development was found to be of high in Group 2 
(NLR 2.05) (P0.001).
Some studies reported that hypercholesterolemia causes 
neutrophilia by enhancing the production of neutrophils and 
their passage from bone marrow into the circulation while 
decreasing their clearance.36 Our results did not show any 
differences among NLR groups regarding hyperlipidemia 
(P0.05) because the mean NLR was 2.04±0.53 in the 
patients with hyperlipidemia, and it was 1.99±0.62 in those 
with normal cholesterol level.
In a few studies, a significant correlation of fasting and post-
prandial blood glucose with WBC count has been reported.37 
Two studies have also indicated a significant relation between 
neutrophil count and blood pressure.38 In our study, starving 
blood glucose level was found to be low in Group 1, which 
was found to be statistically insignificant, and in Group 2 
with high NLR value has high HbA
1c
, which was statistically 
insignificant. The persons who have HT were higher in Group 2 
than in Group 1 and is statistically significant (P=0.022).
A ratio reflecting acute episode of inflammation (increase 
in neutrophil) and acute physiological stress (decrease in 
lymphocyte) has begun to be used recently. Gibson et al18 
demonstrated NLR as a good indicator of inflammation. In 
acute coronary syndrome, lymphopenia can also be observed 
together with the increase in neutrophil. In the study by 
Furman et al39 WBC and subtypes were found to be respon-
sible for cardiovascular events and were emphasized as an 
indicator of inflammation. Kirtane et al40 showed that the 
increase in neutrophil level was associated with extent and 
short-term prognosis of myocardial damage in acute coronary 
syndrome. Thomson et al41 reported that the lymphopenia 
observed in acute coronary syndrome was associated with 
stress-induced cortisol release and that this was one of the 
early findings. In our study, the participants included were 
the persons who had no acute coronary syndrome, the persons 
who had no findings to coronary angiography application, 
and the persons who had suspicious laboratory results.
Papa et al42 emphasized NLR to be an independent pre-
dictor of cardiac events in patients with CAD. Horne et al43 
confirmed NLR to be a predictor of mortality in patients with 
CAD. Gibson et al44 demonstrated NLR to be associated 
with the decrease in survival after coronary artery bypass 
grafting. Another study has indicated that NLR is an inde-
pendent predictor of all-cause mortality in patients having 
percutaneous coronary intervention.45 In the study investi-
gating the progression of coronary atherosclerosis, Kalay et 
al46 reported NLR as an important indicator. In our study, 
NLR was not compared with cardiac events as a predictor. 
But according to our study, we can say that coronary artery 
plaque accumulation, which has potential for cardiac events, 
was found higher in Group 2 (NLR 2.05) and is statistically 
significant (P0.001).
Azab et al conducted a study in patients with T2DM and 
reported cardiac events to be more common in patients with 
high NLR.47 One of the current reviews, which was written by 
Balta et al reported that NLR is an indicator of inflammation, 
and it can be associated with vascular disease.48 Kurtul et al 
mentioned that NLR is independently associated with the 
severity of CAD in patients with non-ST segment elevation 
myocardial infarction.49 Tsai et al conducted a study in T2DM 
patients who have the risk of ischemic CAD and metabolic 
syndrome associated with peripheral leukocyte counts. They 
emphasized that NLR is the risk of ischemic cardiovascular 
disease, especially in T2DM patients who have metabolic 
syndrome.50 In our study, we found that the count of obsCAD 
persons is high in Group 2 (NLR 2.05) and is statistically 
significant (P=0.021). We report that the increased obsCAD 
found in high NLR group is important because of its potential 
danger in future to cause myocardial infarction.
Some studies show that prediabetic condition is associ-
ated with increased cardiovascular risks.51 Additionally, these 
studies demonstrated that the impairment in early markers 
of atherosclerosis is responsible for this process.52,53 Insulin 
resistance is one of the important factor for shaping the future 
of T2DM patients.54 Newman et al emphasized that this is 
genetically determined and an important thing for the future 
of T2DM patients, and it has come out as family history.55 In 
our study, we found similar rates of T2DM family history.
Study limitations
The present study mostly comprised patients who underwent 
MSCT and are being prediagnosed with CAD. This study 
was designed as cross-sectional and retrospective. Thus, 
epidemiological studies are needed to verify the results of 
the present study. Since all the patients were Caucasian, the 
study does not represent other races. The diagnosis of CAD 
was performed only using MSCT. In some cases, there was 
difficulty in detecting the degree of obstruction in terms of 
CAD, rarely in the event of massive calcified plaques on 
MSCT coronary angiography, although respiratory artifacts 
in the patients with respiratory distress caused difficulties in 
differentiation from likely coronary artery soft plaques.
Conclusion
In the present study, the rate of obsCAD was significantly 
higher in the T2DM patients with NLR 2.05 than those with 
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NLR 2.05. In addition to CACS, obsCAD has the potential 
risk of ischemic CAD and is related to cardiac events in 
future, and it was also found to be significantly higher in 
the patients with NLR 2.05 than the patients with NLR 
2.05. According to our study, we can say that the T2DM 
persons who have high NLR value have the increased risk 
of ischemic CAD and cardiac events such as acute coronary 
syndrome and myocardial infarction.
The results of the present study conducted in T2DM 
patients can be summarized in two ways: first, rate of 
obsCAD is significantly higher in those with high NLR 
value, second, coronary calcium risk score, it is seen as the 
predictor of ischemic CAD, is increased in those with high 
NLR value. These results should be supported by further 
comprehensive studies.
Disclosure
The authors report no conflicts of interest in this work.
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